JPRN-UMIN000004910招募中未知
Study of the relationship between antiemetic effect of aprepitrant and genetic polymorphism of ABC transporter - Study of the relationship between antiemetic effect of aprepitrant and genetic polymorphism of ABC transporter
Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka0 个研究点目标入组 100 人开始时间: 2011年2月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Known prior severe hypersensitivity to platinum-containing drug, 5HT3 receptor antagonist, corticosteroids and aprepitant 2) Patients who do not have enough whole body state to the antineoplastic agents treatment 3) Pregnant, breastfeeding or expecting woman 4) Patient with severe uncontrollable diabetes mellitus 5) Known symptomatic brain metastasis 6) Patients who take a medicine regularly such as corticosteroids, dopamine D2-receptor antagonist, phenothiazine tranquilizers, antihistamine drugs and benzodiazepine etc 7) Other clinical difficulties in this study
研究者
相似试验
招募中
3 期
Prophylactic antiemetic effects of Ondansetron and Haloperidol patients undergoing mastectomy- double-blind clinical trialIRCT20240224061097N1Iran University of Medical Sciences50
已完成
3 期
Antagonism Research Between Antiemetics Agents and Acetaminophen in Thyroidectomy's Post-operative Analgesia.Interaction Between Antiemetic Drugs and ParacetamolNCT01679093University Hospital, Lille66
已完成
不适用
Study of the influence of antiemetic drugs on the electroencephalogram during anesthesiaAdult patients who were scheduled to undergo noncranial surgery.JPRN-UMIN000025833Kyoto Chubu Medical Center (Nantan General Hospital)200
已完成
4 期
Investigation of the efficacy of an antiemetic, aprepitant and its drug interaction with prednisolone in CHOP or R-CHOP therapynon-Hodgkin lymphomaJPRN-UMIN000004495Division of Hematology, University of Tsukuba12
已完成
不适用
Comparison of antiemetic effectiveness and safety of palonosetron and dexamethasone with palonosetron, dexamethasone and aprepitant in patients with lung cancer receiving combination therapy with carboplatin: A phase II randomized studylung cancerJPRN-UMIN000010056Hamamatsu University School of Medicine80